View in EDS HTML Full Text PDF Full Text

KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.

Saved in:
Bibliographic Details
Title: KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.
Authors: Rosell, Rafael1,2,3 (AUTHOR) rrosell@iconcologia.net, Jantus-Lewintre, Eloisa4,5,6,7,8 (AUTHOR) ejantus@btc.upv.es, Cao, Peng9,10,11,12 (AUTHOR) cao_peng@njucm.edu.cn, Cai, Xueting9 (AUTHOR), Xing, Baojuan9 (AUTHOR), Ito, Masaoki13 (AUTHOR), Gomez-Vazquez, Jose Luis1,14 (AUTHOR), Marco-Jordán, Mireia1 (AUTHOR), Calabuig-Fariñas, Silvia4,5,6,15 (AUTHOR), Cardona, Andrés Felipe16 (AUTHOR), Codony-Servat, Jordi1,17 (AUTHOR), Gonzalez, Jessica1 (AUTHOR), València-Clua, Kevin1 (AUTHOR), Aguilar, Andrés2 (AUTHOR), Pedraz-Valdunciel, Carlos18 (AUTHOR), Dantes, Zahra19 (AUTHOR), Jain, Anisha20 (AUTHOR), Chandan, S20 (AUTHOR), Molina-Vila, Miguel Angel17 (AUTHOR), Arrieta, Oscar21 (AUTHOR)
Source: Cell Communication & Signaling. 6/12/2024, Vol. 22 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1478811X
DOI:10.1186/s12964-024-01667-x